Search Results
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France
Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
session dedicated to the metastatic forms of PCC and PGL was reported in a special issue of Endocrine-Related Cancer ( Dahia et al. 2020 ). Here we summarize some key insights on the genetics of these tumors published or presented over the past years
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK
Search for other papers by Paul Benjamin Loughrey in
Google Scholar
PubMed
Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
Search for other papers by Estelle Healy in
Google Scholar
PubMed
Search for other papers by Philip Weir in
Google Scholar
PubMed
Search for other papers by Madhu Basetti in
Google Scholar
PubMed
Search for other papers by Ruth T Casey in
Google Scholar
PubMed
Search for other papers by Steven J Hunter in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
reported in association with MAX variants include endometrial carcinoma, ganglioneuromas, neuroblastoma, pancreatic cancer, lung adenocarcinoma and breast cancer ( Walker et al. 2018 , Seabrook et al. 2021 ). In one study, germline MAX variants
Search for other papers by Susan Richter in
Google Scholar
PubMed
Search for other papers by Timothy J Garrett in
Google Scholar
PubMed
Search for other papers by Nicole Bechmann in
Google Scholar
PubMed
Department of Endocrinology, Royal North Shore Hospital, St Leonards, Australia
Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
Search for other papers by Hans K Ghayee in
Google Scholar
PubMed
homolog 1 and 2 ( EGLN1/2 ), kinesin family member 1B ( KIF1B ), DNA methyltransferase 3α ( DNMT3A ), and endothelial PAS domain-containing protein 1 ( EPAS1 or HIF2A ) ( Jhawar et al. 2022 ). Additionally, somatic mutations in these or other cancer
University of Sydney, Camperdown, New South Wales, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, New South Wales, Australia
Search for other papers by Dahlia F Davidoff in
Google Scholar
PubMed
Department of Endocrinology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
Search for other papers by Eugénie S Lim in
Google Scholar
PubMed
University of Sydney, Camperdown, New South Wales, Australia
Search for other papers by Diana E Benn in
Google Scholar
PubMed
Search for other papers by Yuvanaa Subramaniam in
Google Scholar
PubMed
Search for other papers by Eleanor Dorman in
Google Scholar
PubMed
School of Medicine, University of Tasmania, Hobart, Tasmania, Australia
Search for other papers by John R Burgess in
Google Scholar
PubMed
Department of Endocrinology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
Search for other papers by Scott A Akker in
Google Scholar
PubMed
University of Sydney, Camperdown, New South Wales, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, New South Wales, Australia
Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
tumour suppressor SIRT3 Node-positive breast cancer TNFa and TNFb Tumour necrosis Relates to neurological development ARX Non-syndromic intellectual disability and brain malformations CTDP1 Congenital cataract
Search for other papers by Liang Zhang in
Google Scholar
PubMed
Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Search for other papers by Joakim Crona in
Google Scholar
PubMed
, Fishbein et al. 2021 ). While core needle biopsy (CNB)-based disease characterization is now facilitating individualized anti-cancer therapy strategies for many tumor entities, lacking effective therapy is the current therapeutic dilemma in metastatic